Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is Rp 2.120.003,73, with a 24-hour trading volume of Rp 18,02T. The asset's market cap is Rp 5,23P, after moving -1.42% in the last day.
Tokenized Merck & Co Inc is trading at Rp 2.170.439,24, with a tokenized market cap of Rp 687,26B and a 24-hour trading volume of Rp 18,15B. The tokenized asset has moved -2.85% in the past 24 hours.